OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy
Chong Qiu, Yanyan Wu, Qiaoli Shi, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 3, pp. 789-810
Open Access | Times Cited: 21

Showing 21 citing articles:

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 301

The Cutting Edge Quest: Epic Saga of Carboxymethyl Guar Gum in Drug Delivery and Roads Ahead
Vaishali Thakur, Sonia Dhiman, Thakur Gurjeet Singh, et al.
Polymers for Advanced Technologies (2025) Vol. 36, Iss. 2
Closed Access

Folate-Targeted Nanocarriers Co-Deliver Ganciclovir and miR-34a-5p for Combined Anti-KSHV Therapy
Fangling Li, Dongdong Cao, Wenyi Gu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2932-2932
Open Access | Times Cited: 3

Novel inhibitor against Rac1 for therapeutic approach in prevention of breast cancer progression
Anudwipa Singh, Tirthankar Koley, Deepak Vats, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

New insights into the antimicrobial action and protective therapeutic effect of tirapazamine towards Escherichia coli-infected mice
Zhouhui Wu, Yu Wang, Lei Li, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106923-106923
Closed Access | Times Cited: 3

What lower the development of nanodrug?
Chong Qiu
Deleted Journal (2024) Vol. 2, Iss. 1, pp. 460-460
Open Access

Mitochondrial ALDH2 improves ß‐cell survival and function against doxorubicin‐induced apoptosis by targeting CK2 signaling
Udayakumar Karunakaran, Eun Yeong Ha, Suma Elumalai, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 6, pp. 684-692
Open Access

The biomedical application of inorganic metal nanoparticles in aging and aging-associated diseases
Yuqing Meng, Junzhe Zhang, Yanqing Liu, et al.
Journal of Advanced Research (2024)
Open Access

Nucleic acids as drug targets
Bùi Thanh Tùng, Vu Thi Thu Trang, Nguyễn Thị Vân Anh
Elsevier eBooks (2024), pp. 71-97
Closed Access

Biophysical significance of fluorescence spectroscopy in deciphering nucleic acid dynamics: From fundamental to recent advancements
Vivek Pandey, Tejasvi Pandey
Biophysical Chemistry (2024) Vol. 316, pp. 107345-107345
Closed Access

Engineering an Ultrasound-Responsive Glycopolymersome for Hepatocyte-Specific Gene Delivery
Ping Wei, Kai Chen, Jinghua Chen
Biomacromolecules (2024)
Closed Access

Polyethyleneimine-based biomaterials for therapy and diagnostic applications
Mimansa, Pranjali Yadav, Asifkhan Shanavas
Elsevier eBooks (2024), pp. 179-195
Closed Access

Nucleus-targeted Silencer nanoplatform regulating ZEB1-AS1 in head and neck squamous cell carcinoma therapy
Haojie Yang, Yangfan Zhang, Zicong Tan, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access

INVESTIGATION OF THE EFFECT OF COPPER OXIDE NANOPARTICLES ON THE EFFICACY OF METHOTREXATE AND PACLITAXEL IN MCF-7 BREAST CANCER CELLS
Sara Khezri, Farah Farokhi, Yaghub Pazhang
Studies in Medical Sciences (2024) Vol. 35, Iss. 8, pp. 662-674
Closed Access

Bioengineered chimeric tRNA/pre‐miRNAs as prodrugs in cancer therapy
Fatemeh Rafieenia, Seyed Omar Ebrahimi, Ensieh sadat Emadi, et al.
Biotechnology Progress (2023) Vol. 39, Iss. 6
Closed Access | Times Cited: 1

Design and Synthesis of Gefitinib Derivatives as Potential Drugs fo r Cancer Treatment: Antiproliferative Activity, Molecular Docking, and ADMET Prediction
Xiaoyan Ma, Min Shan, Yunlong Lu
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 9, pp. 1555-1568
Closed Access

What lower the development of nanodrug?
Chong Qiu
Deleted Journal (2023) Vol. 1, Iss. 1, pp. 55-55
Open Access

Page 1

Scroll to top